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multidimensionality of QoL can be assessed properly this way;
especially in this speciﬁc situation where the owners are proxy
reporters but also responsible for the well-being of the animal
and therefore likely to be biased.
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OBJECTIVE: A European STARR registry was set-up to deter-
mine the short-term safety and effectiveness of the STARR
procedure for obstructed defaecation syndrome. METHODS:
STARR registries in Italy, Germany and the UK were designed
with a web-based interface to allow pooling of results for com-
bined analysis. Recruitment commenced in January 2006. Data
collection included a symptom severity score (SSS), obstructed
defaecation score (ODS), Cleveland clinic incontinence score,
symptom-speciﬁc (PAC-QoL) and generic (ED-5Q utility and
VAS) QoL score. All complications were recorded. Data collec-
tion was performed at baseline, 6 weeks, and 6 and 12 months.
RESULTS: A total of 1456 patients were recruited and eligible
for analysis. There were 214 (14.7%) male patients. The mean
age was 54 yrs (range: 17–92). Mean operative time was 44mins
(range: 15–210). Average length of stay was 3 days (range:1–36).
By September 2007, 698 (48%) and 422 (29%) were eligible for
analysis at 6 and 12 months. respectively. A signiﬁcant symptom-
atic improvement was seen between baseline and 6 months and
maintained at 12 months (SSS: baseline 24.1 (95%CI: 23.8,24.4)
v’s 12 months 12.5 (95%CI: 12.1,12.9), p < 0.001; ODS: base-
line 15.3 (95%CI: 14.9,15.6) v’s 12 months 5.8 (95%CI:
4.8,6.7), p < 0.001. This was reﬂected in a signiﬁcant improve-
ment in both PAC-QoL and ED-5Q QoL scores at both 6 and
12 months. Incontinence scores improved from 3.1 (95%CI:
2.9,3.3) at baseline to 2.9 (95%CI: 2.1,2.7) at 6 months and
1.9 (95%CI: 1.5,2.2) at 12 months (p < 0.001). 457 minor and
major complications were reported, of which the most frequent
were: unexpected pain (7.7%), urinary retention (6.8%), bleed-
ing (4.5%), stapled line complications (3.2%), sepsis (1.4%),
incontinence (1.3%). Postoperative defaecatory urgency was
reported in 17% of patients. There was no mortality. CONCLU-
SION: STARR for ODS is safe,effective and signiﬁcant improve-
ment in QoL.
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COMMUNITY-DWELLING ELDERLY:A REVIEW
Gomes T1, Chandra KM2
1Ministry of Health and Long-Term Care,Toronto, ON, Canada,
2Program for Assessment of Technology in Health, Hamilton, ON,
Canada
OBJECTIVE: As part of a broader analysis on aging in the
community, the purpose is to perform a literature review to assess
the effectiveness of interventions designed to prevent falls and
fall-related injuries in community-dwelling elderly individuals.
METHODS: A search was performed in OVID MEDLINE,
MEDLINE In-Process and Other Non-Indexed Citations,
EMBASE, CINAHL, Cochrane Library, and INAHTA/NHS EED
between January 2000 and September 2007. Furthermore, all
studies included in a Cochrane review published in 2003 were
considered for inclusion. Studies were included if they were con-
trolled trials in a population of community dwelling elderly and
examined falls or fall-related injuries as an outcome. RESULTS:
Fifty-nine studies were identiﬁed investigating the effectiveness of
nine interventions. A meta-analysis found that exercise programs
effectively reduced falls if they were 6 months or longer in dura-
tion (RR = 0.84 [95% CI: 0.76–0.93]) or were offered to the
general population and not a high risk group (RR = 0.79 [0.70–
0.90]). Environmental modiﬁcations were effective in individuals
with a history of falls (RR = 0.66 [0.54–0.81]), and a gait
stabilizing device for outdoor winter use effectively reduced
falls (RR = 0.43 [0.29–0.64]) and injurious falls (RR = 0.10
[0.01–0.74]). Although neither hormone replacement therapy or
vitamin D alone reduced falls or injuries, vitamin D plus calcium
supplementation resulted in a reduction in the number of falls
(RR = 0.83 [0.73–0.95]) and fractures (RR = 0.60 [0.39, 0.94]).
Multifactorial interventions were only marginally effective in
reducing falls in a high risk population (RR = 0.87 [0.76–1.01]),
and there was no evidence that vision interventions or hip pro-
tectors were effective. CONCLUSION: Several interventions
were identiﬁed which reduce the risk of falls and fall-related
injuries in community-dwelling elderly, however special con-
sideration must be given to the intervention duration and
population risk proﬁle when determining the most appropriate
interventions to implement. An economic analysis that informs
investment decisions to maximize the impact of reducing falls is
currently underway.
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OBJECTIVE: Contraceptive efﬁcacy depends both on patient
compliance and the characteristics of the method used. Efﬁcacy
rates can thus vary across different populations, particularly in
women employing user-dependent methods (i.e., oral, condoms).
This study measured the contraceptive failure rates in a Medicaid
and a non-Medicaid population and evaluated the efﬁcacy
variance between the two groups. METHODS: Monthly
contraceptive-use histories were constructed for all women using
data from the 2002 National Survey of Family Growth (NSFG
VI). Contraceptive use was deﬁned by ﬁrst contraception method
mentioned in the survey. Poly-modal use was not deﬁned.
Women were classiﬁed as Medicaid enrollees if they reported
having Medicaid coverage in the 12 months prior to the survey,
or reported Medicaid payment for services. The ﬁnal dataset
included 1208 Medicaid-enrolled women and 6435 non-
Medicaid enrolled women. Pregnancy rates were calculated each
month and then annualized for women using user-dependent
methods (oral contraceptives [OC], condom) or non-daily
methods (IUD, injected, implanted birth control). RESULTS:
Average annual contraceptive failure rates for Medicaid vs. non-
Medicaid women were: oral pill—1.15% vs 0.13% (p = 0.0051);
condom—2.05% vs. 0.55% (p = 0.0015); IUD—0.52% vs.
0.16% (p = 0.5156); injected or implanted—0.27% vs. 0.13%
(p = 0.3940). OC failure rate was nearly 9-times higher in the
Medicaid population than in the non-Medicaid population. Fail-
ures rates for IUD, injectables and implants were also higher but
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the differences were not statistically signiﬁcant. CONCLUSION:
Study results largely correspond to previous published esti-
mates (i.e., Trussell, 2004). Contraception failure rates for user-
dependent methods were substantially greater in a Medicaid
population than those in a non-Medicaid plan. The efﬁcacy rates
of non-daily methods were not statistically different across the
two populations and thus may be the more appropriate option
for a Medicaid patient or other patient subpopulations shown to
have compliance issues.
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OBJECTIVE: Most studies of potentially inappropriate medica-
tions (PIMs) among older adults have focused on prevalence
rather than incidence. This study determined one-year incidence
of PIMs use among Indiana Medicaid beneﬁciaries 65 years old
or older who resided in nursing homes and examined associa-
tions between incident PIM use and hospitalizations and mortal-
ity. METHODS: A retrospective analysis was conducted using
Indiana Medicaid claims and enrollment ﬁles. Individuals were
included in the sample if they were 65 years old or older, received
Medicaid covered nursing home services from October 2002
through 12 months after starting a PIM in 2003 or until death in
2003, and were prescribed at least one new medication in 2003.
Individuals who received any PIM in the three months prior to
January 2003 were excluded. The 2003 Beers criteria were used
to identify PIMs. Associations between incident PIM use, hospi-
talization and mortality were assessed using logistic regression
models that controlled for age, gender, race, marital status,
Charlson comorbidity scores, number of medications prescribed
in 2003, and nursing home location. Selection bias was examined
using seemingly unrelated bivariate probit models. STATA
Intercooled for Windows was used for all statistical analyses.
RESULTS: The study sample consisted of 7594 individuals. One-
year incidence PIM use was 42.1%. Rhos, correlations of error
terms from equations predicting hospitalizations and mortality,
were not signiﬁcant indicating no selection bias. Incident PIM
users were more likely to be hospitalized (odds ratio
{OR} = 1.27, 95% C.I. 1.10–1.47) and more likely to die
(OR = 1.45, 95% C.I. 1.31–1.61) in 12 months after controlling
for demographic and clinical characteristics. CONCLUSION:
Incidence of PIM prescribing was high among elderly Indiana
Medicaid beneﬁciaries residing in nursing homes. Individuals
who began use of a PIM in 2003 were at a higher risk of
hospitalization and at higher risk of dying.
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OBJECTIVE: Comparison of data collected in a electronic
medical record (EMR) database on men age 21 years and older
with and without erectile dysfunction (ED) on concomitant drug
prescription, co-morbid conditions, smoking status and BMI.
METHODS: A retrospective review of the General Electric
Centricity MQIC research database containing the ambulatory
health records of US patients was conducted. ED patients age 21
and older were identiﬁed by diagnosis, PDE5 and/or both; 18
month of activity and smoking status was required. Two non-ED
age-matched (within +/-2 years) controls were randomly selected
for and linked to each case. A matched case-control analysis was
conducted using conditional logistic regression, with goodness of
ﬁt and residual analyses used to test validity and assumptions.
RESULTS: Non-smokers compared to current smokers were less
likely to develop ED. There was an increase odds of ED with each
unit increase in BMI. Men with BMI 30–39.9 had the highest risk
of ED (2.14 OR, 1.73–2.64 95% CI) compared to those with
BMI  18.5. Antihypertensive, lipid lowering agents and diuret-
ics had the highest relative odds for ED respectively (2.43 OR,
2.34–2.5 95% CI; 1.57 OR, 1.52–1.62 95% CI; 1.44 OR, 1.37–
1.5 95% CI). None of the other risk factors or co-morbid con-
ditions (cerebrovascular disease, kidney disease, anti-
arrhythmics, and anti-neoplastics) was found to increase the risk
of ED. CONCLUSION: EMR data provides a means for assess-
ing risk factors for and associated conditions consistent with ED
in a real-world setting, including the links between this condition
and commonly used prescription drugs. The likelihood of devel-
oping ED was less for non-smokers and increased with increasing
BMI and the use of antihypertensives, lipid lowering agents and
diuretics.
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OBJECTIVE: To generate national estimates of the effect of
injury severity on the incidence and associated resource
utilization-related outcomes of deep vein thrombosis (DVT)
among pediatric traumatic injury inpatient admissions in the
United States. METHODS: Data from the 2003 HCUP
KID dataset were analyzed for 240,387 hospital stays
(unweighted = 146,512) for traumatic injury in patients 20
years old. Among these hospitalizations, cases of DVT were
identiﬁed. Injury severity scores (ISS) were calculated using the
ICDMAP90 software; four mutually exclusive categories corre-
sponding to increasing severity were created. Weighted regression
models estimated the effect of injury severity on the likelihood of
DVT, controlling for patient- and hospital-speciﬁc characteris-
tics. Additional models including interaction terms for DVT/
injury severity category estimated the joint effect of these
parameters on total costs and LOS. RESULTS: Among traumatic
injuries identiﬁed, 648 patients (0.27%) had an ICD-9-CM
code consistent with DVT, similar to previous estimates in the
literature. Among observations with complete data, moderate
[ISS = 9–15], severe [ISS = 16–24] and critical [ISS = 25+])
injuries increased the likelihood of DVT (Odds Ratio
[p-value] = 2.13 [<0.0001], 2.49 [0.0001], and 3.53 [<0.0001],
respectively), as compared to minor injuries (ISS = 0–8). Relative
to minor injuries, severe and critical injuries among those with
DVT (i.e., interactive effects) were associated with increased
LOS. DVT and increasing severity each independently increased
total costs, but interactive effects were not signiﬁcant. CONCLU-
SION: In this study we quantify the effect of injury severity on
the incidence and utilization-related outcomes of DVT among
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